Entrada Therapeutics, Inc. · NASDAQ:TRDA
Sethuraman Natarajan had 2,079 Entrada Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Sep 2, 2026 · Filed Sep 3, 2026
On Sep 2, 2026, Sethuraman Natarajan (President, Research & Develop.) had 2,079 Entrada Therapeutics, Inc. shares withheld for tax at US$7.14 for US$14,844, leaving 214,238 shares. Filed Sep 3, 2026 (Form 4).
- Withheld for tax
- 2,079 shares
- Price
- US$7.14
- Value
- US$14,844
- Holding after
- 214,238 shares
- Trading plan
- No
- Role
- President, Research & Develop.
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Shares withheld for tax | 2,079 | US$7.14 | 214,238 | Direct |
Source
Related
- Entrada Therapeutics, Inc.
- Sethuraman Natarajan
- Entrada Therapeutics, Inc. shareholders
- Form 4 · Sethuraman Natarajan · May 4, 2026
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026